1Tadokoro M, Tsukasaki S, Miyazaki M, et al. Cryoglobulinemia.Nippon Rinsho 2004;62:554 - 558.
2Ramos- Casals M, Trejo O. Triple association between hepatitis C virus infection, systemic autoimmune diseases and B cell lymphoma.J Rheumatol 2004; 31 : 495 - 499.
3Kopec M, Kucharz EJ. Mixed cryoglobulinemia. Pol Arch Med Wewn 2001 ; 106:955 - 956.
4Ferri C, Lacivita L, Longombardo G, et al. Mixed cryoglobulinemia: a cross - road between autoimmune and lymphoproliferative disorders. Lupus 1998 ; 7 : 275 - 279.
4Ferri C, Sebastiani M, Giuggioli D, et al. Mixed cryoglobulinemia : demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum ,2004,33:355-374.
5Tarantino A, Campise M, Banff G, et al. Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. Kidney Int, 1995,47:618-623.
6Brouet JC, Clauvel JP, Danon F, et al. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med, 1974,57:775-788.
8Pascual M, Perrin L, Giostra E, et al. Hepatitis C virus in patients with cryoglobulinemia type Ⅱ. J Infect Dis, 1990,162:569-570.
9Ferri C, Matzo E, Longombardo G, et al. Alpha interferon in the treatment of mixed cryoglobulinaemia patients. Eur J Cancer, 1991,27 Suppl 4:S81-82.
10Monti G, Galli M, Invemizzi F, et al. Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinaemias. QJM, 1995,88: 115-126.
